Review of teriflunomide and its potential in the treatment of multiple sclerosis

por Clemens Warnke, Gerd Meyer zu Hörste, Hans-Peter Hartung, Olaf Stüve, et al.
Publicado 2009

FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.

por Gerd Meyer zu Hörste, Steffen Cordes, Anne K Mausberg, Alla L Zozulya, Carsten Wessig, Tim Sparwasser, Christian Mathys, Heinz Wiendl, Hans-Peter Hartung, Bernd C Kieseier
Publicado 2014

Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.

por Gerd Meyer zu Hörste, Anne K Mausberg, Johanna I Müller, Helmar C Lehmann, Stefan Löber, Peter Gmeiner, Hans-Peter Hartung, Olaf Stüve, Carsten Korth, Bernd C Kieseier
Publicado 2011

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

por Alexander U Brandt, Hanna Zimmermann, Falko Kaufhold, Julia Promesberger, Sven Schippling, David Finis, Orhan Aktas, Christian Geis, Marius Ringelstein, E Bernd Ringelstein, Hans-Peter Hartung, Friedemann Paul, Ilka Kleffner, Jan Dörr
Publicado 2012

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy

por Michael A. Tortorici, Theresa Yuraszeck, David Cornblath, Vera Bril, Hans‐Peter Hartung, Gen Sobue, Richard A. Lewis, Ingemar S. J. Merkies, John‐Philip Lawo, Michaela Praus, Billie L. Durn, Orell Mielke, Xuewen Ma, Petra Jauslin, Marc Pfister, Ivo N. vanSchaik, the PATH study group
Publicado 2021